July 21, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
July 21, 2022 Comments Off on New patent for Cardinal Health drug LYMPHOSEEK KIT Posted in: Patent Added Annual Drug Patent Expirations for LYMPHOSEEK+KIT Lymphoseek Kit is a drug marketed by Cardinal Health 414 and is included in one NDA. It is available from one supplier. There are…
The post New patent for Cardinal Health drug LYMPHOSEEK KIT appeared fi…
